The Weekly Roundup: February 12-16

POLL: What Topical Retinoid Do You Most Often Prescribe?

Click here to answer this week’s acne poll.

Traveling Skin Cancer Screenings Boost Awareness and Early Detection

The Skin Cancer Foundation’s initiative, Destination Healthy Skin, travels to various cities throughout the country in an RV, wherein volunteer dermatologists provide on-the-street, free-of-cost skin screenings.

Derm In The News: February 4-10

Keep up with the latest headlines in dermatology from the past week, including biotech's potential role in alleviating symptoms of skin disease, new sun safety guidelines in Australia, and more.

National Rosacea Society Launches Seal of Acceptance Program

Alongside expert dermatologists, the NRS recently developed a Seal of Acceptance for skin care and cosmetic products clinically tested and evaluated for patients with rosacea.

Physician–Machine Partnerships Capable of Enhancing Clinicians' Diagnostic Accuracy in Varying Skin Tones and Disease

A recent study revealed improvements in sensitivity but highlighted disparities in diagnostic accuracy, particularly among non-specialists and in darker skin tones.

First Patient Dosed in Phase 2a Trial of AX-158 for Psoriasis

Artax announced that safety and efficacy data is expected in the second half of the year.

Pointers With Portela: Potentially Harmful Tween Skin Care

In this week’s Pointers With Portela, the 208SkinDoc discusses the recent trend of tweens buying excessive skin care.

Dermavant Submits sNDA to FDA for Tapinarof Cream 1% to Treat AD Down to 2 Years

Tapinarof cream demonstrated highly statistically significant improvement in the primary end point of vIGA-AD treatment success over vehicle at week 8.

Journal Digest: February 14

This week’s collection of the latest dermatologic studies covers the causal relationship between lipid-related metabolites and androgenic alopecia, contact allergens in self-tanning products, a retrospective cross-sectional analysis of vitiligo patients in Canada, and combining systemic anti-PD-1 treatment with adjuvant ablative fractional laser in a mouse model of cutaneous SCC.

Citius Resubmits BLA of Denileukin Diftitox for Relapsed or Refractory Cutaneous T-Cell Lymphoma

The resubmission follows the Complete Response Letter Citius received from the US FDA in July of 2023.

FDA Accepts Galderma’s BLA for Nemolizumab for the Treatment of Prurigo Nodularis and Atopic Dermatitis

The FDA has also granted nemolizumab Priority Review for prurigo nodularis.

POLL: Are You Attending Masterclasses in Dermatology?

Click here to answer our poll about the upcoming conference in Puerto Rico.

First Known Canadian Study Evaluates Real-World Experiences of Patients With Vitiligo in Community Setting

Researchers noted that this study's findings are consistent with prior epidemiologic data.

Case Study Reports Multiple Giant Cell Collagenomas Associated With Cowden Syndrome

A case report examined an incidence of storiform collagenoma, also known as sclerotic fibroma, associated with Cowden syndrome in a patient. This occurrence is considered rare.

Contact Allergens Lurking in Self-Tanners

An analysis of popular self-tanners revealed that more than half of them contained at least 10 potential allergens, and some contained 20 or more.

POLL: Are You Attending Winter Clinical Miami 2024?

Click here to answer our poll about the upcoming conference.

Previewing Editorial Advisory Board Member Sessions at Winter Clinical Miami 2024

Among the many sessions to be held at the Winter Clinical Miami 2024 Conference in Miami Beach, Florida, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

SkinCure Oncology Receives Patent for New Image-Guided Superficial Radiation Therapy

New data on the devices will be available at the 2024 American Academy of Dermatology Annual Meeting.

Answers to Top 3 Skin Performance Testing Questions

In this month’s Cosmetic Conundrums column, explore skin barrier assessments, skin moisturization tests, and how to measure skin firmness.

New Melanoma Metastasis Risk Prediction Tool Debuts

The test may help patients with melanoma safely avoid a sentinel lymph node biopsy.

Mike Siegel, PhD: What's Coming Up in 2024 for PeDRA

In an interview with Dermatology Times, the executive director of Pediatric Dermatology Research Alliance (PeDRA) discusses the group's growth since 2012 and what it can offer practicing dermatologists, researchers, students, and patients.

POLL: Have You Heard of the New AAD Acne Guidelines?

We want to know your thoughts on the recent guidelines. Share with us by answering our poll or emailing us at DTEditor@mmhgroup.com.

2024 Masterclasses in Dermatology Sneak Peek With Alice Gottlieb, MD, PhD

Learn what makes the Masterclasses in Dermatology conference a unique educational opportunity, and take a quick poll to tell us what you want to learn.

IFPA Announces Launch of Care Roadmap and Action Playbook for Psoriatic Disease

The IFPA Forum Roadmap for Asia outlines key advocacy demands and practical strategies to improve psoriatic care throughout the continent.

Addition of Niosomal Atorvastatin 1% Ointment to Therapy With Topical Calcineurin Inhibitor Yields No Additional Effect in Non-Segmental Vitiligo

The combination therapy did not yield any effect in patients with non-segmental vitiligo and prompts additional large studies prior to conclusive efficacy.

Injected Hyaluronic Acid Stimulates Collagen Production in Photoaged Skin

An investigation into skin changes at the cellular level provides insight into hyaluronic acid’s benefits.

Case Report: Repigmentation of the Lips Using Ruxolitinib

Dive into a complex case report of a 29-year-old African American male patient with Fitzpatrick skin type V with a 6-month reported history of vitiligo on his lips.

Japan Approves Dupilumab for Chronic Spontaneous Urticaria

Japan is the first country in the world to approve dupilumab for the treatment of chronic spontaneous urticaria (CSU).

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.